Tokai Pharma (TKAI) Posts Q1 Loss of 59c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts TKAI Hot Sheet
Join SI Premium – FREE
Tokai Pharma (NASDAQ: TKAI) reported Q1 EPS of ($0.59), $0.28 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Tokai Pharma (TKAI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Knight Transportation (KNX) shares increasingly attractive after pullback, says analyst
- TD Cowen on Pepsico (PEP): 'Ongoing Weakness in North America Drives Guidance Cut'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
